The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Takahiro Iwamoto

Department of Pharmacology

School of Medicine

Fukuoka University

Fukuoka 814-0180

Japan

[email]@cis.fukuoka-u.ac.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Department of Pharmacology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan. 2004 - 2007

References

  1. Na+/Ca2+ exchange inhibitors: a new class of calcium regulators. Iwamoto, T., Watanabe, Y., Kita, S., Blaustein, M.P. Cardiovasc. Hematol. Disord. Drug. Targets (2007) [Pubmed]
  2. Na+/Ca2+ exchange as a drug target--insights from molecular pharmacology and genetic engineering. Iwamoto, T. Ann. N. Y. Acad. Sci. (2007) [Pubmed]
  3. Vascular Na+/Ca2+ exchanger: implications for the pathogenesis and therapy of salt-dependent hypertension. Iwamoto, T. Am. J. Physiol. Regul. Integr. Comp. Physiol. (2006) [Pubmed]
  4. Hypertension, Na+/Ca2+ exchanger, and Na+, K+-ATPase. Iwamoto, T., Kita, S. Kidney Int. (2006) [Pubmed]
  5. Topics on the Na+/Ca2+ exchanger: role of vascular NCX1 in salt-dependent hypertension. Iwamoto, T., Kita, S. J. Pharmacol. Sci. (2006) [Pubmed]
  6. YM-244769, a novel Na+/Ca2+ exchange inhibitor that preferentially inhibits NCX3, efficiently protects against hypoxia/reoxygenation-induced SH-SY5Y neuronal cell damage. Iwamoto, T., Kita, S. Mol. Pharmacol. (2006) [Pubmed]
  7. Salt-sensitive hypertension, Na+/Ca2+ exchanger, and vascular smooth muscle. Iwamoto, T., Kita, S., Katsuragi, T. Trends Cardiovasc. Med. (2005) [Pubmed]
  8. Sodium-calcium exchange inhibitors: therapeutic potential in cardiovascular diseases. Iwamoto, T. Future. Cardiol (2005) [Pubmed]
  9. Molecular determinants of Na+/Ca2+ exchange (NCX1) inhibition by SEA0400. Iwamoto, T., Kita, S., Uehara, A., Imanaga, I., Matsuda, T., Baba, A., Katsuragi, T. J. Biol. Chem. (2004) [Pubmed]
  10. Development and application of Na+/Ca2+ exchange inhibitors. Iwamoto, T., Kita, S. Mol. Cell. Biochem. (2004) [Pubmed]
  11. The exchanger inhibitory peptide region-dependent inhibition of Na+/Ca2+ exchange by SN-6 [2-[4-(4-nitrobenzyloxy)benzyl]thiazolidine-4-carboxylic acid ethyl ester], a novel benzyloxyphenyl derivative. Iwamoto, T., Inoue, Y., Ito, K., Sakaue, T., Kita, S., Katsuragi, T. Mol. Pharmacol. (2004) [Pubmed]
  12. Forefront of Na+/Ca2+ exchanger studies: molecular pharmacology of Na+/Ca2+ exchange inhibitors. Iwamoto, T. J. Pharmacol. Sci. (2004) [Pubmed]
  13. Salt-sensitive hypertension is triggered by Ca2+ entry via Na+/Ca2+ exchanger type-1 in vascular smooth muscle. Iwamoto, T., Kita, S., Zhang, J., Blaustein, M.P., Arai, Y., Yoshida, S., Wakimoto, K., Komuro, I., Katsuragi, T. Nat. Med. (2004) [Pubmed]
  14. Endothelin-1 aggravates hypoxia/reoxygenation-induced injury in renal epithelial cells through the activation of a Na+/Ca2+ exchanger. Iwamoto, T., Kita, S., Katsuragi, T. J. Cardiovasc. Pharmacol. (2004) [Pubmed]
 
WikiGenes - Universities